Richard G. Ball

5.7k total citations
157 papers, 4.2k citations indexed

About

Richard G. Ball is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Richard G. Ball has authored 157 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Organic Chemistry, 43 papers in Molecular Biology and 32 papers in Inorganic Chemistry. Recurrent topics in Richard G. Ball's work include Nuclear Materials and Properties (16 papers), Organometallic Complex Synthesis and Catalysis (16 papers) and Radioactive element chemistry and processing (14 papers). Richard G. Ball is often cited by papers focused on Nuclear Materials and Properties (16 papers), Organometallic Complex Synthesis and Catalysis (16 papers) and Radioactive element chemistry and processing (14 papers). Richard G. Ball collaborates with scholars based in United States, United Kingdom and Canada. Richard G. Ball's co-authors include Nancy N. Tsou, Sheo B. Singh, W. A. G. GRAHAM, Deborah L. Zink, Nicholas C. Payne, A. D. McMaster, James K. Hoyano, Robin W. Grimes, Michael Goetz and Alan P. Kozikowski and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Chemistry and Chemical Communications.

In The Last Decade

Richard G. Ball

156 papers receiving 4.0k citations

Peers

Countries citing papers authored by Richard G. Ball

Since Specialization

Citations

This map shows the geographic impact of Richard G. Ball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard G. Ball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard G. Ball more than expected).

Fields of papers citing papers by Richard G. Ball

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard G. Ball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard G. Ball. The network helps show where Richard G. Ball may publish in the future.

Co-authorship network of co-authors of Richard G. Ball

This figure shows the co-authorship network connecting the top 25 collaborators of Richard G. Ball. A scholar is included among the top collaborators of Richard G. Ball based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard G. Ball. Richard G. Ball is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fragment-based lead discovery of a novel class of small molecule antagonists of neuropeptide B/W receptor subtype 1 (GPR7) 2020 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Nicholas B. Hastings, Zhiqiang Guo, Ming Wang, Jerry Di Salvo, Ying Li, (unknown), Qiaoling Deng, Vincent Tong, (unknown), Richard G. Ball, Feroze Ujjainwalla	8
2	The discovery of potent antagonists of NPBWR1 (GPR7) 2011 ·Bioorganic & Medicinal Chemistry Letters ·F. Anthony Romero, Nicholas B. Hastings, (unknown), Zhiqiang Guo, (unknown), Jerry Di Salvo, Ying Lei, (unknown), Qiaolin Deng, Vincent Tong, (unknown), Richard G. Ball, Feroze Ujjainwalla	5
3	Discovery ofN-[(4R)-6-(4-Chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a Novel Cannabinoid-1 Receptor (CB1R) Inverse Agonist for the Treatment of Obesity 2010 ·Journal of Medicinal Chemistry ·Lin Yan, (unknown), John S. Debenham, (unknown), Julie Lao, Richard Z. Chen, Jing Chen Xiao, Chun-Pyn Shen, D. Sloan Stribling, Lauren P. Shearman, Alison M. Strack, Nancy N. Tsou, Richard G. Ball, Junying Wang, Xinchun Tong, Thomas J. Bateman, (unknown), Tung M. Fong, Jeffrey J. Hale	15
4	Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·Paul J. Coleman, John D. Schreier, Georgia B. McGaughey, Michael J. Bogusky, Christopher D. Cox, George D. Hartman, Richard G. Ball, C. Meacham Harrell, Duane R. Reiss, Thomayant Prueksaritanont, Christopher J. Winrow, John J. Renger	12
5	The discovery of potent, selective, and orally bioavailable hNK1 antagonists derived from pyrrolidine 2007 ·Bioorganic & Medicinal Chemistry Letters ·Peter Lin, (unknown), Robert J. DeVita, Jonathan R. Young, (unknown), Xinchun Tong, Song Guo Zheng, Richard G. Ball, Nancy N. Tsou, Gary G. Chicchi, Marc M. Kurtz, Kwei‐Lan Tsao, Alan Wheeldon, Emma Carlson, Waisi Eng, H. Donald Burns, Richard Hargreaves, Sander G. Mills	11
6	Synthesis of C2-symmetric trans-2,6-diarylpiperidinones via aryl cuprate addition: an unexpected stereochemical outcome 2007 ·Tetrahedron Letters ·Christopher L. Hamblett, David L. Sloman, Laura T. Kliman, (unknown), Richard G. Ball, Matthew G. Stanton	7
7	Development of a pharmaceutical cocrystal of a monophosphate salt with phosphoric acid 2006 ·Chemical Communications ·(unknown), (unknown), Andrey Peresypkin, Robert M. Wenslow, Narayan Variankaval, Cécile Savarin, (unknown), David J. Mathre, Peter G. Dormer, (unknown), Richard G. Ball, Zhixiong Ye, Yaling Wang, (unknown)	80
8	Cyclopentane-based human NK1 antagonists. Part 2: Development of potent, orally active, water-soluble derivatives 2006 ·Bioorganic & Medicinal Chemistry Letters ·Laura C. Meurer, Paul E. Finke, Karen Owens, Nancy N. Tsou, Richard G. Ball, Sander G. Mills, Malcolm MacCoss, Sharon Sadowski, Margaret A. Cascieri, Kwei‐Lan Tsao, Gary G. Chicchi, Linda A. Egger, Silvi Luell, Joseph M. Metzger, D. Euan MacIntyre, N.M.J. Rupniak, Angela Williams, Richard Hargreaves	21
9	Synthesis and muscarinic receptor pharmacology of a series of 4,5,6,7-tetrahydroisothiazolo[4,5-c]pyridine bioisosteres of arecoline 1999 ·Bioorganic & Medicinal Chemistry ·Henrik Pedersen, Hans Bräuner‐Osborne, Richard G. Ball, Karla Frydenvang, Eddi Meier, Klaus P. Bøgesø, Povl Krogsgaard‐Larsen	2
10	Barceloneic Acid A, a New Farnesyl-Protein Transferase Inhibitor from a Phoma Species 1995 ·Journal of Natural Products ·Hiranthi Jayasuriya, Richard G. Ball, Deborah L. Zink, Jack L. Smith, Michael Goetz, Rosalind G. Jenkins, Mary Nallin-Omstead, Keith C. Silverman, Gerald F. Bills, Russell B. Lingham, Sheo B. Singh, Fernando Peláez, Carmen Cascales	40
11	Tryptophan-Derived NK1 Antagonists: Conformationally Constrained Heterocyclic Bioisosteres of the Ester Linkage 1995 ·Journal of Medicinal Chemistry ·Richard T. Lewis, Angus M. MacLeod, Kevin J. Merchant, Fintan Kelleher, Ian R. Sanderson, Richard H. Herbert, Margaret A. Cascieri, Sharon Sadowski, Richard G. Ball, Karst Hoogsteen	50
12	Identification of 3,5-Dihydro-2-aryl-1H-pyrazolo[3,4-c]quinoline-1,4(2H)-diones as Novel High-Affinity Glycine Site N-Methyl-D-aspartate Antagonists 1995 ·Journal of Medicinal Chemistry ·Angus M. MacLeod, Sarah Grimwood, Cheryl L. Barton, Linda J. Bristow, Kay L. Saywell, George Marshall, Richard G. Ball	35
13	Alloys of uranium with transition metals of groups VB to VIIB 1994 ·Springer eBooks ·Richard G. Ball, (unknown), C. Keller	1
14	Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformation. 1994 ·Bioorganic & Medicinal Chemistry ·Peter D. Williams, Richard G. Ball, Bradley V. Clineschmidt, J. Chris Culberson, Jill M. Erb, Roger Freidinger, Joseph Pawluczyk, Debra S. Perlow, Douglas J. Pettibone, Daniel F. Veber	4
15	Methoxylation of cocaine reduces binding affinity and produces compounds of differential binding and dopamine uptake inhibitory activity: discovery of a weak cocaine "antagonist" 1993 ·Journal of Medicinal Chemistry ·Daniele Simoni, (unknown), Alan P. Kozikowski, Kenneth M. Johnson, John S. Bergmann, Richard G. Ball	59
16	Synthesis and biological activity of 8a-phenyldecahydroquinolines as probes of PCP's binding conformation. A new PCP-like compound with increased in vivo potency 1992 ·Journal of Medicinal Chemistry ·Chinpiao Chen, Alan P. Kozikowski, Paul L. Wood, Ian J. Reynolds, Richard G. Ball, Yuan‐Ping Pang	7
17	Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3-hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester 1992 ·Journal of Medicinal Chemistry ·N. N. Girotra, Tesfaye Biftu, Mitree M. Ponpipom, John J. Acton, Alfred W. Alberts, Tobias Bach, Richard G. Ball, Robert L. Bugianesi, John C. Chabala	22
18	Inhibition of human leukocyte elastase. 4. Selection of a substituted cephalosporin (L-658,758) as a topical aerosol 1992 ·Journal of Medicinal Chemistry ·Paul E. Finke, Shrenik K. Shah, Bonnie M. Ashe, Richard G. Ball, Thomas J. Blacklock, Robert J. Bonney, (unknown), Gilbert O. Chandler, Mark F. Cotton	45
19	Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptide 1990 ·Journal of Medicinal Chemistry ·Mark G. Bock, Robert M. DiPardo, Paul Williams, Douglas J. Pettibone, Bradley V. Clineschmidt, Richard G. Ball, Daniel F. Veber, Roger Freidinger	26
20	The ground-state energy of the e^-₂e⁺system calculated by the Green function Monte Carlo method 1988 ·Journal of Physics B Atomic Molecular and Optical Physics ·Richard G. Ball, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact